The Upregulation of L1CAM by SVHRSP Mitigates Neuron Damage, Spontaneous Seizures, and Cognitive Dysfunction in a

Zhen Li1, Biying Ge1,2, Haoqi Li1

  • 1National-Local Joint Engineering Research Center for Drug Research and Development (R&D) of Neurodegenerative Diseases, Dalian Medical University, Dalian 116044, China.

Biomolecules
|July 29, 2025
PubMed

Insights

Scorpion venom peptide (SVHRSP) effectively treated drug-resistant temporal lobe epilepsy (TLE) in rats. It reduced seizures, improved cognition, and protected neurons by enhancing L1CAM-mediated synapse function.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Temporal lobe epilepsy (TLE) is a prevalent, drug-resistant epilepsy often linked to cognitive and emotional deficits.
  • Existing therapies for TLE are limited, necessitating the development of novel therapeutic strategies.
  • Scorpion Venom Heat-Resistant Synthetic Peptide (SVHRSP) exhibits potential anti-epileptic and neuroprotective properties.

Purpose of the Study:

  • To investigate the anti-epileptic and neuroprotective effects of SVHRSP in a kainic acid-induced TLE rat model.
  • To elucidate the underlying molecular mechanisms, particularly the role of L1CAM, in SVHRSP's therapeutic action.

Main Methods:

  • Induction of TLE in rats using kainic acid (KA).
  • Administration of SVHRSP and assessment of seizure frequency and severity.
  • Behavioral testing including novel object recognition, object location, T-maze, and open-field tests.
  • Histological analysis of hippocampal tissue for neuronal loss and glial activation.
  • Transcriptomic analysis to identify affected pathways.
  • Western blotting and immunofluorescence to evaluate protein expression (MAP2, NFL, PSD95, L1CAM).

Main Results:

  • SVHRSP treatment significantly reduced seizure frequency and severity in the TLE rat model.
  • SVHRSP administration improved cognitive functions and reduced anxiety-like behaviors.
  • Histological examination revealed mitigation of hippocampal neuronal loss and glial activation.
  • Transcriptomic data indicated SVHRSP upregulates genes in adhesion molecule-triggered and axon guidance pathways.
  • SVHRSP restored expression of dendritic, axonal, and synaptic markers and increased L1CAM fragment L1-70 levels.
  • L1CAM blockade diminished SVHRSP's neuroprotective effects, highlighting L1CAM's crucial role.

Conclusions:

  • SVHRSP demonstrates significant therapeutic potential for drug-resistant TLE.
  • The anti-epileptic and neuroprotective effects of SVHRSP are mediated, at least in part, through L1CAM-associated synaptic mechanisms.
  • This study provides novel insights into SVHRSP as a potential treatment for TLE, targeting L1CAM-mediated pathways.